Stocktoria
Tempest Therapeutics, Inc. TPST
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-10-04
Tempest Therapeutics, Inc. statistics & valuation
Market cap$16.0M
P / B2.4×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -155.1% | -100.9% | -57.1% | -77.5% | -38.6% |
| Return on equity | -393.9% | -218.8% | -110.2% | -197.2% | -78.4% |
| Debt / equity | — | 0.33× | 0.39× | 0.57× | 0.42× |
| Current ratio | 2.50 | 2.21 | 4.29 | 4.53 | 3.44 |
Source: SEC EDGAR filings · CIK 0001544227 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.